India · Delayed Price · Currency is INR Shukra Pharmaceuticals Statistics
Total Valuation
BOM:524632 has a market cap or net worth of INR 19.09 billion. The enterprise value is 19.00 billion.
| Market Cap | 19.09B |
| Enterprise Value | 19.00B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
BOM:524632 has 437.88 million shares outstanding. The number of shares has increased by 53.87% in one year.
| Current Share Class | 437.88M |
| Shares Outstanding | 437.88M |
| Shares Change (YoY) | +53.87% |
| Shares Change (QoQ) | -7.61% |
| Owned by Insiders (%) | 41.59% |
| Owned by Institutions (%) | n/a |
| Float | 46.74M |
Valuation Ratios
The trailing PE ratio is 229.83.
| PE Ratio | 229.83 |
| Forward PE | n/a |
| PS Ratio | 52.72 |
| PB Ratio | 29.01 |
| P/TBV Ratio | 29.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 118.94, with an EV/FCF ratio of -349.61.
| EV / Earnings | 158.84 |
| EV / Sales | 52.46 |
| EV / EBITDA | 118.94 |
| EV / EBIT | 149.19 |
| EV / FCF | -349.61 |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.80 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.24 |
| Debt / FCF | -0.69 |
| Interest Coverage | 14.13 |
Financial Efficiency
Return on equity (ROE) is 19.92% and return on invested capital (ROIC) is 20.71%.
| Return on Equity (ROE) | 19.92% |
| Return on Assets (ROA) | 9.48% |
| Return on Invested Capital (ROIC) | 20.71% |
| Return on Capital Employed (ROCE) | 18.24% |
| Weighted Average Cost of Capital (WACC) | 10.09% |
| Revenue Per Employee | 3.15M |
| Profits Per Employee | 1.04M |
| Employee Count | 115 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 0.85 |
Taxes
In the past 12 months, BOM:524632 has paid 12.78 million in taxes.
| Income Tax | 12.78M |
| Effective Tax Rate | 9.65% |
Stock Price Statistics
The stock price has increased by +123.72% in the last 52 weeks. The beta is 1.06, so BOM:524632's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +123.72% |
| 50-Day Moving Average | 48.40 |
| 200-Day Moving Average | 29.34 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 345,302 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524632 had revenue of INR 362.10 million and earned 119.59 million in profits. Earnings per share was 0.19.
| Revenue | 362.10M |
| Gross Profit | 275.37M |
| Operating Income | 127.32M |
| Pretax Income | 132.37M |
| Net Income | 119.59M |
| EBITDA | 159.70M |
| EBIT | 127.32M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 133.58 million in cash and 37.56 million in debt, with a net cash position of 96.02 million or 0.22 per share.
| Cash & Cash Equivalents | 133.58M |
| Total Debt | 37.56M |
| Net Cash | 96.02M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 658.06M |
| Book Value Per Share | 1.38 |
| Working Capital | 489.20M |
Cash Flow
In the last 12 months, operating cash flow was -26.77 million and capital expenditures -27.57 million, giving a free cash flow of -54.33 million.
| Operating Cash Flow | -26.77M |
| Capital Expenditures | -27.57M |
| Free Cash Flow | -54.33M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 76.05%, with operating and profit margins of 35.16% and 33.03%.
| Gross Margin | 76.05% |
| Operating Margin | 35.16% |
| Pretax Margin | 36.56% |
| Profit Margin | 33.03% |
| EBITDA Margin | 44.11% |
| EBIT Margin | 35.16% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.02%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.02% |
| Dividend Growth (YoY) | -90.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.66% |
| Buyback Yield | -53.87% |
| Shareholder Yield | -53.85% |
| Earnings Yield | 0.63% |
| FCF Yield | -0.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 21, 2025. It was a forward split with a ratio of 10.
| Last Split Date | Mar 21, 2025 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |